Home › Funds › Palo Alto Investors LP › ANAB

Palo Alto Investors LP position in ANAB

ANAPTYSBIO INC · Health Care

Palo Alto Investors LP reported holding 595,264 shares of ANAB (ANAPTYSBIO INC) in its Q3 2026 13F filing — a position valued at US$29.9M, representing 4.45% of its reported portfolio and ranking #10 among its reported holdings. Palo Alto Investors LP has disclosed ANAB holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)595.26K sh
Reported value held$29.92M
Portfolio Weight4.45%
First reportedQ3 2023
Last changeReduce
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Palo Alto Investors LP's ANAB position evolved

Palo Alto Investors LP first disclosed a stake in ANAB in Q3 2023 at 431,224 shares (US$7.7M). The position peaked in Q2 2026 at 603,489 shares, worth US$40.7M. Across 13 filings, Palo Alto Investors LP increased the stake 5 time(s), trimmed it 5 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 595,264 shares valued at US$29.9M — a reduction of -8,225 shares quarter over quarter.. Notable position changes include a 59% increase in Q4 2023 (shares rose 5% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 431.22K $7.74M New
Q4 2023 686.88K $14.71M Add
Q1 2024 799.91K $18.01M Add
Q2 2024 803.64K $20.14M Hold
Q3 2024 843.97K $28.27M Add
Q4 2024 843.97K $11.17M Hold
Q1 2025 1.02M $18.98M Add
Q2 2025 812.82K $18.04M Reduce
Q3 2025 673.52K $20.62M Reduce
Q4 2025 690.03K $33.45M Add
Q1 2026 638.16K $35.39M Reduce
Q2 2026 603.49K $40.74M Reduce
Q3 2026 595.26K $29.92M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ANAB and 13F data

ANAB (ANAPTYSBIO INC) is a Health Care company. 37 other funds we track also report a position in ANAB — the largest reported positions include EcoR1 Capital, LLC (US$396.1M), TANG CAPITAL MANAGEMENT LLC (US$74.1M), Sanofi (US$41.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ANAB

All ANAB fund holders →

FAQ

How long has Palo Alto Investors LP held ANAB?

Palo Alto Investors LP has disclosed ANAB holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Palo Alto Investors LP's current position in ANAB?

As of Q3 2026, Palo Alto Investors LP holds 595.26K shares of ANAB (ANAPTYSBIO INC), valued at $29.92M, representing 4.45% of its reported portfolio and ranking #10.

Has Palo Alto Investors LP been buying or selling ANAB?

In the latest 13F filing (Q3 2026), Palo Alto Investors LP reduced its position in ANAB. The position peaked in Q2 2026 at 603.49K shares.

Which other funds hold ANAB?

Other major institutional holders of ANAB include EcoR1 Capital, LLC, TANG CAPITAL MANAGEMENT LLC, Sanofi, among 37 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.